Last reviewed · How we verify
At least one dose of HAV
At least one dose of HAV is a Biologic drug developed by LiuZhou People's Hospital. It is currently FDA-approved.
At a glance
| Generic name | At least one dose of HAV |
|---|---|
| Sponsor | LiuZhou People's Hospital |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People (PHASE4)
- Autonomous Methadone Delivery System by Nurses (NA)
- TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B (PHASE1)
- A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) (PHASE2)
- Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection (PHASE1, PHASE2)
- Supporting Treatment Outcomes Among PWID (NA)
- A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II) (PHASE1)
- HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- At least one dose of HAV CI brief — competitive landscape report
- At least one dose of HAV updates RSS · CI watch RSS
- LiuZhou People's Hospital portfolio CI
Frequently asked questions about At least one dose of HAV
What is At least one dose of HAV?
At least one dose of HAV is a Biologic drug developed by LiuZhou People's Hospital.
Who makes At least one dose of HAV?
At least one dose of HAV is developed and marketed by LiuZhou People's Hospital (see full LiuZhou People's Hospital pipeline at /company/liuzhou-people-s-hospital).
What development phase is At least one dose of HAV in?
At least one dose of HAV is FDA-approved (marketed).
Related
- Manufacturer: LiuZhou People's Hospital — full pipeline
- Compare: At least one dose of HAV vs similar drugs
- Pricing: At least one dose of HAV cost, discount & access